Home ›
NPI 1366434847
NPI deactivated
1366434847
1366434847 was paid $2.63M by Medicaid between Jan 2018 and Sep 2022, across 124 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 11% of everything it billed.
33Billing provider info1366434847
33aNPI1366434847
33bProvider type—
28Total paid$2.63M
24GClaims467,630
24DCodes billed124
24AFirst – last monthJan 2018 – Sep 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 92,178 | $404K | |
| 2019 | 122,711 | $582K | |
| 2020 | 92,275 | $478K | |
| 2021 | 95,665 | $613K | |
| 2022 | 64,801 | $555K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 11% | 4,273 | 3,675 | $281K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.3% | 9,276 | 7,981 | $218K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.3% | 67,648 | 42,334 | $193K |
| 80053 | Comprehensive metabolic panel | 6.8% | 36,295 | 25,102 | $180K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.5% | 35,515 | 21,132 | $144K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.7% | 5,554 | 5,103 | $123K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.7% | 5,541 | 5,092 | $123K |
| 84484 | 3.6% | 24,841 | 16,065 | $95K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 1,556 | 1,308 | $90K |
| 87040 | 2.5% | 8,110 | 4,197 | $66K | |
| 83735 | 2.5% | 17,573 | 8,519 | $65K | |
| 83880 | 2.3% | 6,209 | 4,588 | $59K |
112 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.2% | 1,658 | $58K |
| 84703 | 2.0% | 15,326 | $53K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.9% | 2,176 | $49K |
| 83690 | 1.7% | 13,221 | $45K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.6% | 7,619 | $42K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 1,422 | $40K |
| 83605 | 1.4% | 8,334 | $36K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 1,228 | $31K |
| 85730 | 1.1% | 9,540 | $30K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 3,650 | $29K |
| 87641 | 1.0% | 1,179 | $27K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 153 | $26K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,109 | $24K |
| 88307 | <1% | 560 | $23K | |
| 81001 | <1% | 16,459 | $22K | |
| 85610 | <1% | 10,663 | $21K | |
| 85027 | <1% | 7,305 | $21K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 378 | $19K |
| 84702 | <1% | 4,374 | $19K | |
| 86901 | <1% | 7,970 | $18K | |
| 85379 | <1% | 4,795 | $18K | |
| 80076 | <1% | 5,549 | $17K | |
| 82805 | <1% | 2,524 | $17K | |
| 86850 | <1% | 5,307 | $15K | |
| 81003 | <1% | 13,853 | $14K | |
| 86900 | <1% | 8,330 | $14K | |
| 87186 | <1% | 1,950 | $11K | |
| 84100 | <1% | 4,800 | $10K | |
| 82550 | <1% | 3,543 | $9K | |
| 80074 | <1% | 479 | $9K | |
| 87210 | <1% | 3,598 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,690 | $8K |
| 80061 | Lipid panel | <1% | 2,970 | $8K |
| 82728 | <1% | 2,072 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 965 | $7K |
| 81025 | <1% | 4,205 | $7K | |
| 87070 | <1% | 2,208 | $6K | |
| 82607 | <1% | 992 | $6K | |
| 86140 | <1% | 2,504 | $6K | |
| 82803 | <1% | 599 | $6K | |
| 87088 | <1% | 927 | $6K | |
| 87806 | <1% | 589 | $5K | |
| 82375 | <1% | 2,267 | $5K | |
| 86592 | <1% | 2,567 | $5K | |
| 80202 | <1% | 748 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 194 | $5K |
| 82247 | <1% | 2,219 | $5K | |
| 87340 | <1% | 759 | $5K | |
| 83615 | <1% | 1,954 | $5K | |
| 80185 | <1% | 680 | $4K | |
| 82553 | <1% | 1,184 | $4K | |
| 82746 | <1% | 725 | $4K | |
| 84145 | <1% | 2,305 | $4K | |
| 82077 | <1% | 374 | $4K | |
| 82570 | <1% | 1,577 | $4K | |
| 83550 | <1% | 892 | $4K | |
| 87077 | <1% | 1,902 | $4K | |
| 88304 | <1% | 207 | $3K | |
| 82150 | <1% | 1,073 | $3K | |
| 83050 | <1% | 2,279 | $3K | |
| 87205 | <1% | 1,926 | $3K | |
| 82140 | <1% | 860 | $3K | |
| 84112 | <1% | 115 | $3K | |
| 87075 | <1% | 555 | $3K | |
| 82248 | <1% | 1,961 | $3K | |
| 82962 | <1% | 3,487 | $3K | |
| 87807 | <1% | 563 | $3K | |
| 87081 | <1% | 950 | $3K | |
| 88342 | <1% | 386 | $3K | |
| 85018 | <1% | 3,389 | $3K | |
| 86706 | <1% | 310 | $2K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 140 | $2K |
| 84550 | <1% | 1,219 | $2K | |
| 87899 | <1% | 318 | $2K | |
| 86922 | <1% | 423 | $2K | |
| 84439 | <1% | 451 | $2K | |
| 86880 | <1% | 599 | $2K | |
| 87493 | <1% | 75 | $2K | |
| 84132 | <1% | 1,031 | $2K | |
| 85652 | <1% | 1,162 | $1K | |
| 80069 | <1% | 344 | $1K | |
| 84156 | <1% | 1,311 | $1K | |
| 86803 | <1% | 157 | $1K | |
| 84300 | <1% | 590 | $1K | |
| 83540 | <1% | 424 | $1K | |
| 86762 | <1% | 261 | $1K | |
| 86704 | <1% | 143 | $1K | |
| 85014 | <1% | 1,098 | $1K | |
| 85384 | <1% | 368 | $1K | |
| 82565 | <1% | 553 | $894.83 | |
| 86480 | <1% | 33 | $857.01 | |
| 83970 | <1% | 43 | $669.08 | |
| 82010 | <1% | 233 | $652.07 | |
| 82948 | <1% | 616 | $528.00 | |
| 85046 | <1% | 175 | $441.14 | |
| 87015 | <1% | 74 | $255.40 | |
| 86038 | <1% | 31 | $244.90 | |
| 84481 | <1% | 48 | $243.76 | |
| 87430 | <1% | 27 | $224.37 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 45 | $199.23 |
| 82009 | <1% | 219 | $187.48 | |
| 82436 | <1% | 83 | $174.75 | |
| 86689 | <1% | 14 | $156.66 | |
| 80164 | <1% | 33 | $146.19 | |
| 82330 | <1% | 21 | $133.60 | |
| 87147 | <1% | 49 | $68.72 | |
| 84133 | <1% | 20 | $42.00 | |
| 83930 | <1% | 18 | $41.94 | |
| 80320 | <1% | 2,138 | $36.86 | |
| 85007 | <1% | 142 | $21.00 | |
| 80329 | 0% | 252 | $0.00 | |
| 86923 | 0% | 77 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.